Perrigo Benefits From McNeil Recall, Prepares Infant Formula Launches
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's extensive recall of leading brand name analgesics spurred sales growth for Perrigo's private-label products in the category during the firm's most recent earnings period